MAP2K7 and neoplasm: Based on the abovementioned studies, compared with RAF inhibitors and MEK inhibitors, ERKis have antitumor effects and can prevent tumor cells from developing drug resistance to a certain extent; thus, they have a broader application prospect in clinical practice.